Schizophrenia Bulletin Open
2023
Tanya M Luhrmann, Xialing Ann Chen, David Baumeister et al.
5 citations
We present a mixed-methods study, from an anthropological perspective, of 22 healthy voice-hearers ie, people who report hearing voices but have no need for clinical care. They were interviewed using the Varieties Of Individual Voice-Experiences Scale (VOICES), a new scale assessing phenomenology, beliefs and relationships with voices, and their emotional and behavioral impact. Despite in many...
BMJ
January 25, 2017
Derek K. Tracy, David M Wood, David Baumeister
117 citations
Thank you for your interest in spreading the word about The BMJ.NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Username * Your Email * Send To * You are going to email the following Novel psychoactive substances: types, mechanisms of action, and...
Clinical Psychology Review
November 1, 2016
David Baumeister, Ottilie Sedgwick, Oliver Howes et al.
234 citations
Recent decades have seen a surge of research interest in the phenomenon of healthy individuals who experience auditory verbal hallucinations, yet do not exhibit distress or need for care. The aims of the present systematic review are to provide a comprehensive overview of this research and examine how healthy voice-hearers may best be conceptualised in relation to the diagnostic versus 'quasi-'...
Therapeutic Advances in Psychopharmacology
January 26, 2015
David Baumeister, Luis M. Tojo, Derek K. Tracy
158 citations
There has been growing clinical, public, and media awareness and concern about the availability and potential harmfulness of so-called ‘legal highs’, which are more appropriately called new or novel psychoactive substances (NPS). A cat-and-mouse process has emerged wherein unknown chemists and laboratories are producing new, and as yet nonproscribed, compounds for human consumption; and as soon...
Therapeutic Advances in Psychopharmacology
August 1, 2014
David Baumeister, Georgina Barnes, Giovanni Giaroli et al.
Hallucinogens have been part of spiritual practice for millennia, but controversy surrounding their mind-manifesting effects led to their proscription by the mid-20th century, largely without evidence of harm or toxicity and despite nascent data suggesting therapeutic utility in treating depressive illnesses. This review explores their pharmacodynamic actions and the current limited data on...